New anal insert aims to stop leakage and improve lives
NCT ID NCT04657588
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new, liquid-filled anal insert (called Navina) to help people with faecal incontinence (accidental bowel leakage). The device is designed to be comfortable and adapt to the body to prevent leaks. Researchers compared it to usual care in 73 adults aged 16-90 to see if it improves quality of life and is cost-effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Navina anal insert (a liquid-filled, single-use rectal device)
What this could lead to
If successful, this device could offer a comfortable, effective option to manage faecal incontinence and improve daily life for people with this condition.
What could go wrong
This is a small, completed trial (73 participants) comparing the device to usual care. Results may not apply to everyone, and the device may not work for all types of faecal incontinence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FAECAL INCONTINENCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Maastricht University Medical Centre
Maastricht, Limburg, 6229HX, Netherlands